논문 상세보기

Mechanisms underlying diabetes-induced bone loss KCI 등재후보

  • 언어ENG
  • URLhttps://db.koreascholar.com/Article/Detail/435416
구독 기관 인증 시 무료 이용이 가능합니다. 4,000원
대한구강생물학회 (The Korean Academy of Oral Biology)
초록

Diabetes, a chronic hyperglycemic condition, is caused by insufficient insulin secretion or functional impairment. Long-term inadequate regulation of blood glucose levels or hyperglycemia can lead to various complications, such as retinopathy, nephropathy, and cardiovascular disease. Recent studies have explored the molecular mechanisms linking diabetes to bone loss and an increased susceptibility to fractures. This study reviews the characteristics and molecular mechanisms of diabetes-induced bone disease. Depending on the type of diabetes, changes in bone tissue vary. The molecular mechanisms responsible for bone loss in diabetes include the accumulation of advanced glycation end products (AGEs), upregulation of inflammatory cytokines, induction of oxidative stress, and deficiencies in insulin/IGF-1. In diabetes, alveolar bone loss results from complex interactions involving oral bacterial infections, host responses, and hyperglycemic stress in periodontal tissues. Therapeutic strategies for diabetes-induced bone loss may include blocking the AGEs signaling pathway, decreasing inflammatory cytokine activity, inhibiting reactive oxygen species generation and activity, and controlling glucose levels; however, further research is warranted.

목차
Introduction
Main Text
    1. 당뇨병 환자에서의 골밀도 변화와 골질환의 특징
    2. 당뇨병에 의한 골소실의 잠재적 기전
    3. 당뇨병에 의한 치조골 소실
Conclusion
Funding
Conflicts of Interest
References
저자
  • Ju Han Song(Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of Korea, Hard-tissue Biointerface Research Center, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of Korea)
  • Xianyu Piao(Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of Korea, Hard-tissue Biointerface Research Center, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of Korea)
  • Jeong-Tae Koh(Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of Korea, Hard-tissue Biointerface Research Center, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of Korea) Corresponding author